Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

About the course

EFFICACY AND SAFETY PROFILE OF BASAL INSULIN – GLP1-RECEPTOR AGONIST COMBINATION THERAPIES

Having completed this e-learning course and its accompanying self-assessment questions, the learner should have gained an increased understanding of:

* The different insulin intensification therapies

* The rationale for combining basal insulin with a GLP1-receptor agonist

* The current published clinical trials evaluating the efficacy and safety outcomes of basal insulin - GLP-1 RA combination therapies

* The improved safety profile of the basal insulin-GLP1-receptor agonist combination

* The convenience of basal insulin-GLP1-receptor agonist combination

* The management of patients for whom treatment with a basal insulin-GLP1-receptor agonist combination would be a viable option

Courses are now online!

Register for the Insulin Educational program and start any available content whenever you want. You can sign up to the E-alert list to be notified when new courses or course modules are uploaded.


Search this site

Search form


 

Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk